Skip to main content
. 2020 Jun 13;21(12):4213. doi: 10.3390/ijms21124213

Figure 7.

Figure 7

Evaluation of oxidation in bone defects one and four weeks after surgery. Bone defects stained with 4-HNE antibodies (for detecting oxidation). D, Dasatinib; Q, Quercetin; LS-G, implantation of LPS-sustained gelatin sponges in bone defects; LS-G+EGCG, implantation of LS-Gs chemically modified with EGCG in bone defects; LS-G+D+Q, oral administration of D+Q with implantation of LS-Gs in bone defects.